Literature DB >> 2703799

Tick-borne viral encephalitis in Finland. The clinical features of Kumlinge disease during 1959-1987.

P Wahlberg1, P Saikku, M Brummer-Korvenkontio.   

Abstract

During 1959-1987, 126 patients in Aland Islands and main Finland had serologically verified infections with the virus of tick-borne encephalitis (Kumlinge disease). The most useful test for specific virological diagnosis was haemagglutination inhibition-IgM (HI-IgM). Most cases were from Aland Islands and nearby south-western main Finland. Two of the infections were imported. There were three laboratory infections and two transfusion infections. The disease occurred mainly from July to September. Detailed hospital records of 108 of the patients could be obtained. Ninety-five per cent of the patients had headaches, 82% had lymphocytosis of the cerebrospinal fluid, and 81% had high fever. Forty-four per cent had a confirmed biphasic course of disease. Seventeen per cent were severely ill. There were no deaths. The sequels were psychic irritability and fatigue for up to 1 year. There were eight cases of paresis, two of which became permanent.

Entities:  

Mesh:

Year:  1989        PMID: 2703799     DOI: 10.1111/j.1365-2796.1989.tb00059.x

Source DB:  PubMed          Journal:  J Intern Med        ISSN: 0954-6820            Impact factor:   8.989


  15 in total

1.  Two-year survey of the incidence of Lyme borreliosis and tick-borne encephalitis in a high-risk population in Sweden.

Authors:  R Gustafson; B Svenungsson; M Forsgren; A Gardulf; M Granström
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1992-10       Impact factor: 3.267

2.  Immunological differentiation between tickborne encephalitis with and without concomitant neuroborreliosis.

Authors:  J Tomazic; A Ihan; F Strle; J Cimperman; J Stare; M Maticic; B Zakotnik
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1997-12       Impact factor: 3.267

Review 3.  Pathogens transmitted in red blood cell transfusions: An up-to-date table.

Authors:  Herbert L Fred; Manoj Thangam; Gabriel M Aisenberg
Journal:  Proc (Bayl Univ Med Cent)       Date:  2018-05-10

4.  Herpes encephalitis is a disease of middle aged and elderly people: polymerase chain reaction for detection of herpes simplex virus in the CSF of 516 patients with encephalitis. The Study Group.

Authors:  M Koskiniemi; H Piiparinen; L Mannonen; T Rantalaiho; A Vaheri
Journal:  J Neurol Neurosurg Psychiatry       Date:  1996-02       Impact factor: 10.154

Review 5.  Tick-borne encephalitis: A review of epidemiology, clinical characteristics, and management.

Authors:  Petra Bogovic; Franc Strle
Journal:  World J Clin Cases       Date:  2015-05-16       Impact factor: 1.337

6.  Infections of the central nervous system of suspected viral origin: a collaborative study from Finland.

Authors:  M Koskiniemi; T Rantalaiho; H Piiparinen; C H von Bonsdorff; M Färkkilä; A Järvinen; E Kinnunen; S Koskiniemi; L Mannonen; M Muttilainen; K Linnavuori; J Porras; M Puolakkainen; K Räihä; E M Salonen; P Ukkonen; A Vaheri; V Valtonen
Journal:  J Neurovirol       Date:  2001-10       Impact factor: 2.643

Review 7.  Tick-borne encephalitis: Clinical findings and prognosis in adults.

Authors:  Reinhard Kaiser
Journal:  Wien Med Wochenschr       Date:  2012-06-14

8.  Tick-bone encephalitis in Sweden in relation to aseptic meningo-encephalitis of other etiology: a prospective study of clinical course and outcome.

Authors:  G Günther; M Haglund; L Lindquist; M Forsgren; B Sköldenberg
Journal:  J Neurol       Date:  1997-04       Impact factor: 4.849

9.  Cognitive impairment after acute encephalitis: comparison of herpes simplex and other aetiologies.

Authors:  L Hokkanen; E Poutiainen; L Valanne; O Salonen; M Iivanainen; J Launes
Journal:  J Neurol Neurosurg Psychiatry       Date:  1996-11       Impact factor: 10.154

10.  Siberian subtype tickborne encephalitis virus, Finland.

Authors:  Anu E Jääskeläinen; Tapani Tikkakoski; Nathalie Y Uzcátegui; Andrey N Alekseev; Antti Vaheri; Olli Vapalahti
Journal:  Emerg Infect Dis       Date:  2006-10       Impact factor: 6.883

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.